In classical Hodgkin lymphoma the combination of the CCR5 antagonist maraviroc with trabectedin synergizes, enhances DNA damage and decreases three-dimensional tumor-stroma heterospheroid viability

Detalles Bibliográficos
Autores principales: Casagrande, Naike, Borghese, Cinzia, Aldinucci, Donatella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719077/
https://www.ncbi.nlm.nih.gov/pubmed/34498447
http://dx.doi.org/10.3324/haematol.2021.279389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719077/
https://www.ncbi.nlm.nih.gov/pubmed/34498447
http://dx.doi.org/10.3324/haematol.2021.279389

Ejemplares similares